Atrial fibrillation and congestive heart failure are commonly occurring cardiac disorders that often exist concomitantly. The prognostic significance of the presence or absence of atrial fibrillation, as an independent risk factor, in patients with heart failure remains controversial. Antiarrhythmic drugs with good hemodynamic profiles and neutral effects on survival are preferred treatments for converting atrial fibrillation and maintaining sinus rhythm. Other standard therapies for congestive heart failure, such as angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers, and beta‐blockers also have a role in the treatment of these coexisting disease states. The article presents an overview of atrial fibrillation in patients with heart failure and reviews the prevalence, prognostic significance, and efficacy of various antiarrhythmic agents for the conversion and maintenance of sinus rhythm. (J Cardiovasc Electrophysiol, Vol. 14, pp. S281‐S286, December 2003, Suppl.) [ABSTRACT FROM AUTHOR]
: |
Copyright of Journal of Cardiovascular Electrophysiology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
-->
Autor: |
NACCARELLI, GERALD V., HYNES, B. JOHN, WOLBRETTE, DEBORAH L., BHATTA, LUNA, KHAN, MAZHAR, SAMII, SORAYA, LUCK, JERRY C. |
Předmět: |
|
Zdroj: |
Journal of Cardiovascular Electrophysiology; Dec2003 Supplement 3, Vol. 14, pS281-S286, 6p, 1 Chart |
Abstrakt: |
AF in Heart Failure. --> Atrial fibrillation and congestive heart failure are commonly occurring cardiac disorders that often exist concomitantly. The prognostic significance of the presence or absence of atrial fibrillation, as an independent risk factor, in patients with heart failure remains controversial. Antiarrhythmic drugs with good hemodynamic profiles and neutral effects on survival are preferred treatments for converting atrial fibrillation and maintaining sinus rhythm. Other standard therapies for congestive heart failure, such as angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers, and beta‐blockers also have a role in the treatment of these coexisting disease states. The article presents an overview of atrial fibrillation in patients with heart failure and reviews the prevalence, prognostic significance, and efficacy of various antiarrhythmic agents for the conversion and maintenance of sinus rhythm. (J Cardiovasc Electrophysiol, Vol. 14, pp. S281‐S286, December 2003, Suppl.) [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|